Long-term benefit of Qarziba uncertain, says NICE

4th May 2018 Uncategorised 0

The National Institute for Health and Care Excellence has ruled against the provision of NHS funding for EUSA Pharma’s neuroblastoma treatment Qarziba.

More: Long-term benefit of Qarziba uncertain, says NICE
Source: News